Prostate cancer Board decisions

The Board has determined that the reduction of the veteran's disability rating for prostate cancer from 100% to 20% was proper, but denied service connection for headaches, a skin disorder, and an immune system disorder.

The veteran's prostate cancer residuals have been rated at 40 percent from January 19, 2001 to August 3, 2004 and at 60 percent since then. The veteran is entitled to a higher rating for his incontinence.

The veteran's prostate cancer and glaucoma and other eye disorders were not found to be related to his military service, including exposure to Agent Orange or ultraviolet light from radar operations.

The Board found that the veteran's prostate cancer and lung disability are not related to his service, including exposure to herbicides.

The Board has remanded the case for further development regarding whether the veteran was exposed to Agent Orange during his active duty training (ADT) and, if so, whether this exposure is related to his prostate cancer.

The veteran's prostate cancer was not incurred in or aggravated by active service, nor may it be presumed to have been incurred in or aggravated by active service. The Board denied the claim of service connection for prostate cancer.

The Board found that the proper procedures for a rating reduction were followed and there is no evidence of any local recurrence, metastasis, or renal dysfunction related to this disorder. The veteran's current urinary frequency does not meet the criteria for a higher rating.

The Board has remanded the case for additional development due to incomplete records and functional loss issues.

The veteran's prostate cancer, status post prostatectomy, is currently rated at 60 percent and the claim for an evaluation in excess of this rating is denied.

The Board found that the veteran's service-connected disabilities did not substantially or materially contribute to his cause of death, which was cardiac arrest due to ischemic cardiomyopathy. The VA doctor concluded that PTSD did not play a role in causing or aggravating the cardiovascular problems.

The Board is remanding the case for further development, including obtaining medical opinions and ensuring proper VCAA notice. The issues of service connection for the cause of death and Dependents' Educational Assistance are being considered together as they may be impacted by the outcome of the service connection claim.

The Board has determined that the veteran's prostate cancer and subsequent radical prostatectomy do not meet the criteria for a 100% disability rating, thus denying restoration of such.

The Board found no evidence of service-connected disabilities that caused or contributed to the veteran's death. The cause of death was attributed to congestive heart failure, hypertension, and renal insufficiency.

The VA denied the veteran's claim for service connection for prostate cancer, finding no evidence of a disease or injury in service and concluding that prostate cancer is not related to his military service.

The veteran's death was not due to a service-connected disability, and the Board is remanding for further development of medical records.

The veteran's claim for compensation benefits under 38 U.S.C.A. § 1151 is denied as there is no competent medical evidence establishing that the treatment he received from VA resulted in any additional disability, to include groin and right lower extremity pain.

The Board has granted service connection for lung cancer, but denied service connection for prostate cancer as there is no medical evidence linking the veteran's prostate cancer to his period of active service.

The veteran seeks service connection for prostate cancer, which he claims was caused by exposure to Agent Orange during his time in Thailand. The VA is instructed to verify the veteran's exposure to Agent Orange and schedule him for a VA examination to determine if his prostate cancer is related to his active service.

The Board denied the veteran's claim for service connection for prostate cancer and postoperative prostatectomy, including as a result of exposure to Agent Orange, finding that there was no evidence linking his condition to his military service or to exposure to herbicides.

The Board has remanded the case for additional development, including obtaining a radiation dose estimate and considering whether the veteran's prostate cancer is related to his exposure to ionizing radiation during service.